. Postmortem human brain sample information for protein, mRNA, and microRNA experiments. Human BLA samples from psychiatricallyhealthy controls (CTRL; n = 21) and depressed subjects having died by suicide (DS; n =16) were matched according to age, sex, postmortem interval (PMI), and brain pH, and did not differ significantly between groups. Group differences were assessed using twotailed Student's t-tests (age, PMI, brain pH) and Fisher's exact test (Sex). Whenever possible protein, mRNA, and microRNA were collected for all subjects; group overlap is depicted by a Venn diagram.
Supplementary Figure 1 . Relative expression of GFRα1a and GFRα1b in the human basolateral amygdala. We assessed the relative expression of GFRα1a and b isoforms in control (CTRL; n = 14) and depressed subjects (DS; n = 13) using quantitative real-time PCR and two sets of primers. Primer Set 1 was previously validated by Yoong and colleagues 35 . For Primer Set 2, GFRα1a mRNA expression was assessed using primers designed to target GFRα1a exon 5 (see Supplementary Table 2 ). The absolute quantity of GFRα1a mRNA was then subtracted from the mRNA expression of all full-length GFRA1 transcripts in order to acquire an estimate of GFRα1b expression. Primer Set 1 and Primer Set 2 yielded remarkably similar results, providing GFRα1a to GFRα1b fold change estimates of 2.042 and 2.049, respectively. Among controls, the ratio of GFRα1a to GFRα1b variants is approximately 1 to 1.9; among depressed subjects, the ratio is lower (1 to 2.6). Thus, in the human BLA GFRα1b mRNA expression is roughly 2-fold higher than GFRα1a expression. 
Supplementary

Supplementary Materials: Methods
Human brain samples
For all subjects, cause of death was determined by the Quebec Coroner's Office, and psychological autopsies completed as previously described 47 . Briefly, the Structured Clinical Interview for DSM-IV Psychiatric Disorders (SCID-I) was completed by a trained interviewer with one or more informants best acquainted with the deceased, and the results assessed by a panel of clinicians in conjunction with Coroner's notes, medical records, and case reports in order to obtain a consensus diagnosis. Age, postmortem interval, and brain pH did not differ between groups.
Isolation and processing of microRNA, mRNA, and protein
Total RNA was isolated from frozen brain samples using either the Lipid Tissue For protein extractions, tissues were lysed in RIPA buffer containing protease and phosphatase inhibitors (Sigma-Aldrich, St. Louis, MO) and homogenized by sonication.
Total protein content was assessed using the BCA Protein Assay kit (Pierce, Rochford, IL).
Immunoblotting
Protein samples were resolved through SDS-PAGE and transferred nitrocellulose membranes. Membranes were blocked at room temperature, then incubated in a solution containing primary antibody, followed by incubation in a solution containing HRPconjugated secondary antibody (see Supplementary Table 3 for a complete list of antibodies used). Signals were revealed with ECL against film and the optical density of target bands assessed using the MCID system (InterFocus Imaging Ltd 
Human NPC transfections
Two weeks after induction of differentiation, NPCs were transfected using HiPerFect transfection reagent alone, or in conjunction with 10nM miScript miR-511 Mimic or 10nM AllStars Negative Control SiRNA (Qiagen, Toronto, ON, Canada). Transfections were completed according to the manufacturer's protocol, and over-expression of miR-511 assessed at 24hrs using qRT-PCR ( Supplementary Fig 8) . For gene expression studies, NPCs were collected 48hrs after transfection and processed for RNA extraction.
For studies examining GDNF-induced immediate early gene (IEG) signaling, cells were collected 72 hours after transfection. For protein expression experiments and Akt/MAPK GDNF signaling studies, NPCs were re-transfected a second time 3.5 days after the initial treatment for a total of 1 week of miR-511 over-expression.
Since HiPerFect-only controls did not differ from AllStars Negative Control SiRNAtransfected cells in any measure examined, all analyses compared miR-511 mimictransfected cells (miR-511) with AllStars Negative Control SiRNA-transfected cells (CTRL).
